A novel immunosuppressive 1α,25-dihydroxyvitamin D3 analog with reduced hypercalcemic activity

Journal of Investigative Dermatology

Volumn 119, Issue 6, 2002, Pages 1434-1442

  Zügel, Ulrich ^a   Steinmeyer, Andreas ^a   Giesen, Claudia ^a   Asadullah, Khusru ^a  

^a BAYER PHARMA AG   (Germany)

Author keywords

Autoimmunity; Inflmmation; Skin; T lymphocytes

Indexed keywords

25 (5 BUTYLOXAZOL 2 YL) 26,27 CYCLO 9,10 SECOCHOLESTA 5,7,10(19),22 TETRAENE 1,3,24 TRIOL; CALCITRIOL; IMMUNOSUPPRESSIVE AGENT; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 12; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VITAMIN D RECEPTOR; ZK 191784; B7 ANTIGEN; CALCITRIOL RECEPTOR; CYTOKINE; DRUG DERIVATIVE; HLA DR ANTIGEN; LIPOPOLYSACCHARIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; CALCIUM HOMEOSTASIS; CELL LINE; CELL PROLIFERATION; CONTACT ALLERGY; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG ACTIVITY; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; FEMALE; HYPERCALCEMIA; IMMUNOMODULATION; IMMUNOPATHOLOGY; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; T LYMPHOCYTE; ANIMAL; AUTOIMMUNE DISEASE; CELL DIFFERENTIATION; CELL DIVISION; CELL STRAIN HL 60; CHEMICALLY INDUCED DISORDER; CHEMISTRY; CONTACT DERMATITIS; CYTOLOGY; DOWN REGULATION; HUMAN; IMMUNOLOGY; METABOLISM; METHODOLOGY; MOUSE STRAIN; SECRETION;

ANIMALS; ANTIGENS, CD80; AUTOIMMUNE DISEASES; CALCITRIOL; CELL DIFFERENTIATION; CELL DIVISION; CYTOKINES; DERMATITIS, CONTACT; DOWN-REGULATION; FEMALE; HL-60 CELLS; HLA-DR ANTIGENS; HUMANS; HYPERCALCEMIA; IMMUNOSUPPRESSION; INTERCELLULAR ADHESION MOLECULE-1; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED STRAINS; MONOCYTES; RECEPTORS, CALCITRIOL; T-LYMPHOCYTES;

EID: 0036886377     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.2002.19623.x     Document Type: Article

References (41)

1. 3 in rheumatoid arthritis patients. Clin Exp Rheumatol 17:453-456, 1999
2. 3. Chem Biol 6:265-275, 1999
3. 3 has a direct effect on naive CD4 + T cells to enhance the development of Th2 cells. J Immunol 167:4974-4980, 2001
4. Bouillon R, Okamura WH, Norman AW: Structure-function relationships in the vitamin D endocrine system. Endocr Rev 16:200-257, 1995
5. 3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. Proc Natl Acad Sci USA 93:7861-7864, 1996
6. Cantorna MT, de Haynes CE, Luca HF: 1,25-Dihydroxycholecalciferol inhibits the progression of arthritis in murine models of human arthritis. J Nutr 128:68-72, 1998
7. Cantorna MT, Munsick C, Bemiss C, Mahon BD: 1,25-Dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease. J Nutr 130:2648-2652, 2000
8. 3. Curr Opin Nephrol Hypertens 4:313-318, 1995
9. 3 in combination with a short induction course of cyclosporine A. Endocrinology 139:95-102, 1998
10. Cher DJ, Mosmann TR: Two types of murine helper T cell clone. Delayed-type hypersensitivity is mediated byTh1 clones. J Immunol 138:3688-3694, 1987
11. Clavreul A, D'Hellencourt C, Montero-Menel C, Potron G, Couez D: Vitamin D differentially regulates B.71 and B.72 expression on human peripheral blood monocytes. Immunology 95:272-277, 1998
12. Enk AH, Katz SI: Early molecular events in the induction phase of contact sensitivity. Proc Natl Acad Sci USA 89:1398-1402, 1992
13. 3 (on the induction of experimental autoimmune thyroiditis. Clin Immunol Immunopathol 54:53-63, 1990
14. Grese TA, Sluka JP, Bryant HU, et al: Molecular determinants of tissue selectivity in estrogen receptor modulators. Proc Natl Acad Sci USA 94:14105-14110, 1997
15. 3 and its analogs: A vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo. Proc Natl Acad Sci USA 98:6800-6805, 2001
16. Hewison M: Vitamin D and the immune system. J Endocrinol 132:173-175, 1992
17. 3: A vitamin D3 metabolite with high affinity for the 1,25-dihydroxyvitamin D specific cytosol receptor. Biochemistry 22:245-250, 1983
18. Jones G, Strugnelli SA, DeLuca HF: Current understanding of the molecular actions of Vitamin D. Physiol Rev 78:1193-1231, 1998
19. 3 prolong rat cardiac allograft survival. In: Norman AW, Schaefer K, Grigoleit HG Von Herrath D (eds). Vitamin D: Molecular, Cellular and Clinical Endocrinology. Berlin: Walter de Gruyter, 1988a; pp 334-345
20. 3 prolongs skin graft survival in mice. In: Norman AW, Schaefer K, Grigoleit HG, Von Herrath D (eds). Vitamin D: Molecular, Cellular and Clinical Endocrinology. Berlin: Walter de Gruyter, 1988b; pp 346-359
21. 3. J Steroid Bio)chem Mol Biol 53:599-602, 1995
22. Lemire JM, Archer DC: 1,25-Dihydroxyvitamin (D)3 (prevents the in vivo induction)of murine experimental autoimmune encephalomyelitis. J Clin Invest 87: 1103-1107, 1991
23. 3 analogue 1,25-dihydroxy-delta 16-cholecalciferol. Transplantation 54:762-763, 1992
24. 3: Preferential inhibition of Th1 functions. J Nutr 125(Suppl): 1704S, 1995
25. 3-induced differentiation in human promyelocytic leukemia cell line (HL-60): Receptor-mediated maturation to macrophage-like cells. J Cell Biol 98:391-393, 1984
26. Mathieu C, Adorini L: The coming of age of 1,25-dihydroxyvitamin D3 analogs as immunomodulatory agents. Trends Mol Med 8:174-179, 2002
27. 3. Eur J Immunol 30:498-508, 2000
28. 3. J Biol Chem 274:16392-16399, 1999
29. Nagpal S, Lu J, Boehm MF: Vitamin D analogs. Mechanism of action and therapeutic applications. Curr Med Chem 8:1661-1679, 2001
30. 3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J Immunol 164:2405-2411, 2000
31. 3 for the treatment of psoriasis. Br J Dermatol 134:1070-1078, 1996
32. 3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells. J Immunol 164: 4443-4451, 2000
33. 3 receptors in human leukocytes. Science 221:1181-1183, 1983
34. 3-treated monocytes. Arthritis Rheum 35: 110-119, 1992
35. 3 calcitriol. J Clin Invest 74:1451-1455, 1984
36. 3. J Clin Invest 79:1659-1664, 1987
37. Schwartz RH: T cell clonal anergy. Curr Opin Immunol 9:351-357, 1997
38. Slatopolsky E,Weerts C, Thielan J, Horst R, Harter H, Martin KJ: Marked suppression of secondary hyperparathroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients. J Clin Invest 74:2136-2143, 1984
39. Steinmeyer A, Kirsch G, Neef G, et al: New vitamin D derivative with carbo- or heterocyclic substituents at C-25, process for their production, intermediate products and their use for producing medicaments. Wo97/ 41096:611, 1997
40. Takeyama K, Masuhiro Y, Fuse H, et al: Selective interaction of vitamin D receptor with transcriptional coactivators by a vitamin D analog. Mol Cell Biol 19: 1049-1055, 1999
41. 3 down-regulation of HLA-DR on human peripheral blood monocytes. Immunology 75:349-354, 1992